COVID-19 Outcomes in Patients Undergoing B Cell Depletion Therapy and Those with Humoral Immunodeficiency States: A Scoping Review
Background: The role of humoral immunity has been well established in reducing infection risk and facilitating viral clearance in patients with COVID-19. However, the relationship between specific antibody responses and severity of COVID-19 is less well understood. Methods: To address this question...
Saved in:
Main Authors: | Jessica Jones (Author), Aiman Faruqi (Author), James Sullivan (Author), Cassandra Calabrese (Author), Leonard Calabrese (Author) |
---|---|
Format: | Book |
Published: |
Case Western Reserve University,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The intersection of COVID-19 and autoimmunity: What is our current understanding?
by: Nicole Eve Winchester, et al.
Published: (2021) -
Case Report: Zellweger Syndrome and Humoral Immunodeficiency: The Relevance of Newborn Screening for Primary Immunodeficiency
by: C. Fazi, et al.
Published: (2022) -
Effects of opioids on proximal renal tubular cells undergoing ATP depletion
by: Luca Bellini, et al.
Published: (2016) -
Is Rituximab-Associated Hypogammaglobulinemia Always Linked to B-Cell Depletion?
by: Anthie Damianaki, et al.
Published: (2022) -
Hormesis and Epidermal Stem Cells
by: Edward J. Calabrese, et al.
Published: (2022)